8-K
Current Report
X4 Pharmaceuticals, Inc Filed Acc 0001628280-23-018424
Material agreement · Unregistered share sale · Regulation FD disclosure · Other events
- Item 1.01 Entry into a material definitive agreement
- Item 3.02 Unregistered sales of equity securities
- Item 7.01 Regulation FD disclosure
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading xfor-20230515.htm…